624 filings
PRER14A
ENTO
Entero Therapeutics Inc.
Preliminary revised proxy
17 Jun 24
5:23pm
424B3
ENTO
Entero Therapeutics Inc.
14 Jun 24
Prospectus supplement
5:15pm
4
ENTO
Entero Therapeutics Inc.
12 Jun 24
Entero Therapeutics / CHAITAN PHD KHOSLA ownership change
6:23pm
EFFECT
ENTO
Entero Therapeutics Inc.
11 Jun 24
Notice of effectiveness
12:15am
8-K
ENTO
Entero Therapeutics Inc.
5 Jun 24
Changes in Registrant's Certifying Accountant
5:15pm
DEFA14A
wd54ye89en8
30 May 24
Additional proxy soliciting materials
5:32pm
8-K/A
4vgn7e 3eoobxoqg
30 May 24
Financial Statements and Exhibits
5:18pm
8-K
199 hco57e
16 May 24
Amendments to Articles of Incorporation or Bylaws
7:16am
8-K
uar70g96l8dxvgq
13 May 24
Entry into a Material Definitive Agreement
5:26pm
424B5
egylbvs e4e152f9jq
13 May 24
Prospectus supplement for primary offering
4:59pm
8-K/A
k6tra fx0i8mn
8 May 24
Independent Auditor’s Report
5:16pm
4
at6rc1c9rhg2waeaz
3 Apr 24
First Wave BioPharma / JAMES SAPIRSTEIN ownership change
5:14pm
4
iv6fewpqxtvmq
3 Apr 24
First Wave BioPharma / Sarah Romano ownership change
5:13pm
8-K
4pevf09wkjy 5dqu1bs
22 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:00pm
4
y82y5o4lvqqg dg8axl
19 Mar 24
First Wave BioPharma / JAMES SAPIRSTEIN ownership change
4:13pm
4
xfxbf 3jl5dd9
19 Mar 24
First Wave BioPharma / Sarah Romano ownership change
4:10pm
8-K
oea17 uc7p
18 Mar 24
First Wave BioPharma Announces Two Abstracts on Celiac Disease Research Accepted for Presentation at the 2024 Digestive Disease Week (DDW) Conference
4:40pm